ArticleJournal of gastrointestinal oncology2026
Machine learning-based gastric cancer risk prediction in an asymptomatic screening population: a retrospective cohort study.
Article in Journal of gastrointestinal oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early detection of gastric cancer is critical for improving survival. Although established risk factors are known, few studies comprehensively assess individual gastric cancer risk across diverse clinical features, particularly within a general screening population. Existing machine learning (ML) models often rely on high-risk clinical cohorts or utilize classification methods that fail to account for the essential time-to-event nature of survival data, thus limiting their utility for developing personalized, long-term screening strategies in asymptomatic individuals. This study aimed to develop and evaluate clinically explainable survival-based ML models for personalized gastric cancer risk stratification during longitudinal follow-up using data from a large cohort of asymptomatic individuals undergoing routine health screening. Methods: Comprehensive medical annual check-up data, including endoscopic findings and blood test results, were collected from 129,223 patients who visited one of the largest medical screening facilities in South Korea between 2007 and 2020. We trained several survival-based ML models [e.g., Extreme Gradient Boosting (XGBoost) Survival, DeepSurv, Random Survival Forest] as well as a conventional Cox Proportional Hazards (CPH) regression model. Model behavior was interpreted using SHapley Additive exPlanations (SHAP). Results: Survival-based ML models demonstrated comparable discrimination performance, with the XGBoost Survival model achieving an average concordance index of 0.78. Conclusions: This study demonstrates the feasibility of applying explainable survival-based ML approaches for gastric cancer risk stratification in a general screening population. While the findings suggest potential clinical relevance, further calibration assessment, external validation, and prospective evaluation are required before translation into clinical decision-making or surveillance strategy development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.